Search research articles
Contact Us
Filters
Showing results (1-10 of 101) with videos related to
Page
of 11
Sort By:
Translational Lung Cancer Research
|
March 26, 2015
EGFR IHC score for selection of cetuximab treatment: Ready for clinical practice?
Martin Früh, Miklos Pless
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2018
EML4-ALK Variant Affects ALK Resistance Mutations
Martin Früh, Solange Peters
Journal of Thoracic Disease
|
June 29, 2018
Immune checkpoint inhibitors and small cell lung cancer: what's new?
Sabine Schmid, Martin Früh
Cancer Cell
|
May 16, 2018
Genomic Features of Response to Combination Immunotherapy in Lung Cancer
Martin Früh, Solange Peters
Translational Lung Cancer Research
|
March 21, 2025
Light on the horizon for HER2 overexpressing non-small cell lung cancer?
Kira-Lee Koster, Martin Früh
The Lancet. Oncology
|
February 7, 2020
Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?
Sabine Schmid, Martin Früh, Solange Peters
Respirology (Carlton, Vic.)
|
March 16, 2013
FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma
Paul M Putora, Martin Früh, Joachim Müller
Onkologie
|
December 18, 2004
Resection of skin metastases from gastric carcinoma with long-term follow-up: an unusual clinical presentation
Martin Früh, Thomas Ruhstaller, Jörg Neuweiler, et al.
Swiss Medical Weekly
|
December 31, 2018
Lung cancer and smoking trends in the young in Switzerland: a study based on data of the National Institute for Cancer Epidemiology and Registration and of the Swiss Health Surveys
Seyed Mohsen Mousavi, Sabine Schmid, Thomas Cerny, et al.
Case Reports in Oncology
|
July 31, 2013
EML4-ALK-Positive Pulmonary Adenocarcinoma with an Unusual Metastatic Pattern: A Case Report
Stefan Diem, Martin Früh, Regulo Rodriguez, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 101) with videos related to
Sort By:
Page
of 11
Translational Lung Cancer Research
|
March 26, 2015
EGFR IHC score for selection of cetuximab treatment: Ready for clinical practice?
Martin Früh, Miklos Pless
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2018
EML4-ALK Variant Affects ALK Resistance Mutations
Martin Früh, Solange Peters
Journal of Thoracic Disease
|
June 29, 2018
Immune checkpoint inhibitors and small cell lung cancer: what's new?
Sabine Schmid, Martin Früh
Cancer Cell
|
May 16, 2018
Genomic Features of Response to Combination Immunotherapy in Lung Cancer
Martin Früh, Solange Peters
Translational Lung Cancer Research
|
March 21, 2025
Light on the horizon for HER2 overexpressing non-small cell lung cancer?
Kira-Lee Koster, Martin Früh
The Lancet. Oncology
|
February 7, 2020
Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?
Sabine Schmid, Martin Früh, Solange Peters
Respirology (Carlton, Vic.)
|
March 16, 2013
FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma
Paul M Putora, Martin Früh, Joachim Müller
Onkologie
|
December 18, 2004
Resection of skin metastases from gastric carcinoma with long-term follow-up: an unusual clinical presentation
Martin Früh, Thomas Ruhstaller, Jörg Neuweiler, et al.
Swiss Medical Weekly
|
December 31, 2018
Lung cancer and smoking trends in the young in Switzerland: a study based on data of the National Institute for Cancer Epidemiology and Registration and of the Swiss Health Surveys
Seyed Mohsen Mousavi, Sabine Schmid, Thomas Cerny, et al.
Case Reports in Oncology
|
July 31, 2013
EML4-ALK-Positive Pulmonary Adenocarcinoma with an Unusual Metastatic Pattern: A Case Report
Stefan Diem, Martin Früh, Regulo Rodriguez, et al.
Page
of 11